3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
9
Lung Neoplasms
8
Hematologic Neoplasms
5
Colorectal Neoplasms
5
Prostatic Neoplasms
4
Hodgkin Disease
4
Carcinoma, Non-Small-Cell Lung
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Motor Activity
3
Pancreatic Neoplasms
2
Obesity
2
Neoplasms
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Hematopoietic and Lymphoid System Neoplasm
2
Gastrointestinal Diseases
2
Cardiotoxicity
2
Urinary Bladder Neoplasms
1
Trastuzumab Cardiotoxicity
1
Small Cell Lung Carcinoma
1
Sedentary Behavior
1
Sarcopenia
1
Polycystic Ovary Syndrome
1
Pelvic Neoplasms
1
Pathologically Proven Gastrointestinal Malignancy
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Myocardial Fibrosis
1
Myelodysplastic Syndromes
1
Multiple Endocrine Neoplasia Type 1
1
Interventions
Metformin
28
Exercise
8
Pioglitazone
7
Inositol
6
Insulin
5
Acupuncture Therapy
4
High-Intensity Interval Training
3
Ethinyl Estradiol
3
salicylsalicylic acid
2
drospirenone and ethinyl estradiol combination
2
Water
2
Tablets
2
Surveys and Questionnaires
2
Sugars
2
Resistance Training
2
Folic Acid
2
Diet Therapy
2
Cyproterone Acetate
2
Caloric Restriction
2
ziprasidone
1
maltodextrin
1
lime
1
exendin (9-39)
1
drospirenone
1
cinnulin PF
1
adrenosterone
1
World Health Organization oral rehydration solution
1
Waist-Hip Ratio
1
Waist Circumference
1
Vitamin D
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Insulin Resistance
×
Exercise Test
×
Clear all
NCT05215223
2023-10-17
WBV
Cairo University
Phase NA
Completed
46 enrolled